SO
CGEM icon

STRS Ohio’s Cullinan Oncology CGEM Stock Holding History

STRS Ohio’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Buy
+1,000
New +$14.8K ﹤0.01% 2119
2024
Q3 		– Sell
-34,100
Closed -$595K – 1982
2024
Q2 		$595K Buy
34,100
+2,200
+7% +$46.8K ﹤0.01% 1108
2024
Q1 		$543K Buy
+31,900
New +$493K ﹤0.01% 1200
2021
Q4 		– Sell
-3,700
Closed -$83K – 2206
2021
Q3 		$83K Buy
3,700
+500
+16% +$13.4K ﹤0.01% 1975
2021
Q2 		$82K Hold
3,200
– – ﹤0.01% 2018
2021
Q1 		$133K Buy
+3,200
New +$130K ﹤0.01% 1884

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

STRS Ohio's CGEM Position: Q2 2026 in Review

STRS Ohio opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 1,000 shares worth $18.2K. The stake represents ﹤0.01% of the portfolio and ranks #2119 among its holdings. This is a return to the name: STRS Ohio previously reported a position in CGEM as recently as Q2 2024.

STRS Ohio first reported a position in CGEM in Q1 2021 and has held it in 6 quarters since. The position peaked at $595K in Q2 2024. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • STRS Ohio held 1,000 shares of Cullinan Oncology worth $18.2K as of Q2 2026.
  • Cullinan Oncology was a new STRS Ohio position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2119 holding.
  • STRS Ohio first reported a position in Cullinan Oncology in Q1 2021 and has held it in 6 quarters since.
  • STRS Ohio's Cullinan Oncology position peaked at $595K in Q2 2024.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.